Search results
364 results found
Dr Laura BlackburnLaura is PHG Foundation's Head of Science, and is responsible for the delivery of the scientific expertise and analysis that underpin our work. She also contributes to the development of our strategic partnerships with other organisations who have an interest in science and health policy.
Tanya BrigdenTanya is a senior policy analyst, working on ethical and legal considerations arising from biomedical innovation and personalised healthcare. She contributes to a broad portfolio of PHG interests, spanning the use of digital technologies, AI and genomics in healthcare and research.
Ofori CanacooOfori is responsible for delivering key communications of PHG Foundation projects and products. With a BA (Hons) in Media Production, Ofori will utilise and expand PHG Foundation's multimedia library.
Dr Chaitanya EradyChaitanya Erady is a policy analyst in biomedical science, contributing to the horizon-scanning health-related innovations, and working on projects related to personalised prevention.
Alison HallAfter stepping down as a Senior advisor, Alison continues her relationship with PHG as an associate. She focuses on data and device regulation that impacts innovations in healthcare.
Bhavya KrishnanPolicy Analyst (Biomedical Science)
Dr Colin MitchellColin is the PHG Foundation's Head of Humanities. He leads the team's work on legal and ethical issues across genomics, novel health technologies, innovative biomedical research and data.
Dr Elizabeth Redrup HillElizabeth is a Senior Policy Analyst (Law and Regulation) in the humanities team. She works on legal and ethical issues for genomics, data, artificial intelligence and other innovative health technologies at the cutting-edge of personalised healthcare.
Nicola SparksNicola is Administration Manager and Executive PA to the Chairman and Director. She manages the Foundation's general administrative functions and also supports the Business and Operations Manager.
Heather TurnerHeather is a biomedical policy analyst who first developed an interest in policy when exploring the evidence base for secondary findings and associated risk estimates in individuals with and without a family history, particularly focusing on the return of results from the 100,000 Genomes Project.